Zobrazeno 1 - 10
of 80
pro vyhledávání: '"RICHARD M. TEREK"'
Autor:
Richard M. Terek, Qian Chen, Jesse Hart, Ross Taliano, Jose Ramirez, Ashna Alladin, Jason T. Machan, Hongchuan Yu, Yupeng Chen, Xiaojuan Sun
Chondrosarcoma is a highly aggressive primary malignant bone tumor mostly occurring in adults. There are no effective systemic treatments, and patients with this disease have poor survival. miR-181a is an oncomiR that is overexpressed in high-grade c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07ac43948ce3883ae4d488bbe5b8aa65
https://doi.org/10.1158/1535-7163.c.6538324.v1
https://doi.org/10.1158/1535-7163.c.6538324.v1
Chondrosarcoma is the most common primary malignant bone tumor in adults, has no effective systemic treatment, and patients with this disease have poor survival. Altered expression of microRNA (miR) is involved in tumorigenesis; however, its role in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2889508ebffb86aa05797a6457434acd
https://doi.org/10.1158/1541-7786.c.6540118.v1
https://doi.org/10.1158/1541-7786.c.6540118.v1
Supplemental figures 1-4. S1. Analysis miR-181a copy numbers in gDNA samples with TaqMan Copy Number Assay. A-D, are representative images for negative control, CS-1, JJ, and Huvec samples. E, miR-181a copy number was calculated from absolute quantif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88a140d93a29fb18584bdf878c6b9c8b
https://doi.org/10.1158/1541-7786.22512076
https://doi.org/10.1158/1541-7786.22512076
Autor:
Richard M. Terek, Qian Chen, Jesse Hart, Ross Taliano, Jose Ramirez, Ashna Alladin, Jason T. Machan, Hongchuan Yu, Yupeng Chen, Xiaojuan Sun
Lung metastatic burden quantified as number of nodules per lung and area of nodules as a percent of total lung area.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb38a50e9caedb4c526fe2e8a4c83389
https://doi.org/10.1158/1535-7163.22506205.v1
https://doi.org/10.1158/1535-7163.22506205.v1
Autor:
Brian D. Snyder, Timothy A. Damron, Michael Yaszemski, Richard M. Terek, Edward Y. Cheng, Mark C. Gebhardt, Megan E. Anderson, Robert Turcotte, Albert J. Aboulafia, Felix H. Cheung, Patrick P. Lin, Juan C. Villa-Camacho, John A. Hipp, Nathan Calderon, David Zurakowski, Vahid Entezari, Ara Nazarian
Appendix A. Calculation of Structural Rigidity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::465848fc4257e8e80fb16465ba3dab4c
https://doi.org/10.1158/1078-0432.22459232
https://doi.org/10.1158/1078-0432.22459232
Autor:
Brian D. Snyder, Timothy A. Damron, Michael Yaszemski, Richard M. Terek, Edward Y. Cheng, Mark C. Gebhardt, Megan E. Anderson, Robert Turcotte, Albert J. Aboulafia, Felix H. Cheung, Patrick P. Lin, Juan C. Villa-Camacho, John A. Hipp, Nathan Calderon, David Zurakowski, Vahid Entezari, Ara Nazarian
Purpose: Pathologic fractures could be prevented if reliable methods of fracture risk assessment were available. A multicenter prospective study was conducted to identify significant predictors of physicians' treatment plan for skeletal metastasis ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c701dca6d5a549a467f3436fe60ccd5
https://doi.org/10.1158/1078-0432.c.6524171
https://doi.org/10.1158/1078-0432.c.6524171
Autor:
Michael H Bernstein, Maayan N Rosenfield, Charlotte Blease, Molly Magill, Richard M Terek, Julian Savulescu, Francesca L Beaudoin, Josiah D Rich, Karolina Wartolowska
Randomised placebo-controlled trials (RPCTs) are the gold standard for evaluating novel treatments. However, this design is rarely used in the context of orthopaedic interventions where participants are assigned to a real or placebo surgery. The pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12bd47e3768ed908fa9ddde9c08fbe99
https://ora.ox.ac.uk/objects/uuid:3a623e5a-9a72-400b-8318-047afedccb64
https://ora.ox.ac.uk/objects/uuid:3a623e5a-9a72-400b-8318-047afedccb64
Autor:
Richard M. Terek
Publikováno v:
Clin Orthop Relat Res
BACKGROUND: The management of primary malignant bone tumors in patients with metastatic disease at presentation remains a challenge. Although surgical resection has been a mainstay in the management of nonmetastatic malignant bone tumors, there is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::070244a3f68ee5807ffff83ee361d2df
https://doi.org/10.1097/corr.0000000000001431
https://doi.org/10.1097/corr.0000000000001431
Autor:
Xiaojuan, Sun, Yupeng, Chen, Hongchuan, Yu, Jason T, Machan, Jesse, Hart, Qian, Chen, Richard M, Terek
Publikováno v:
Trans Annu Meet Orthop Res Soc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::79107c371a701c030c782e438af34b7e
https://pubmed.ncbi.nlm.nih.gov/34526732
https://pubmed.ncbi.nlm.nih.gov/34526732
Autor:
Richard M. Terek, Jason T. Machan, Ashna Alladin, Jesse Hart, Xiaojuan Sun, Hongchuan Yu, Ross Taliano, Yupeng Chen, Jose M. Ramirez, Qian Chen
Publikováno v:
Mol Cancer Ther
Chondrosarcoma is a highly aggressive primary malignant bone tumor mostly occurring in adults. There are no effective systemic treatments, and patients with this disease have poor survival. miR-181a is an oncomiR that is overexpressed in high-grade c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4db609df11f67a4618408101b355dcc
https://doi.org/10.1158/1535-7163.mct-18-1020
https://doi.org/10.1158/1535-7163.mct-18-1020